Immunocore Holdings plc

IMCR ·Healthcare, Drug Manufacturers - General, United Kingdom
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022
Assets
Cash & Equivalents $467.7M $455.7M $442.6M $402.5M
Accounts Receivable — $63.0M $52.1M $33.6M
Inventory $6.7M $5.4M $4.5M $692.0K
Total Current Assets $996.7M $929.9M $528.8M $474.0M
Property, Plant & Equipment $11.5M $10.1M $9.2M $7.8M
Goodwill — — — —
Intangible Assets (Excl. Goodwill) — — — —
Total Assets $1.07B $1.01B $597.0M $526.8M
Liabilities
Accounts Payable $24.4M $25.1M $17.8M $14.5M
Total Current Liabilities $246.7M $212.2M $139.0M $100.8M
Long-Term Debt — — — —
Total Liabilities $686.2M $648.8M $228.2M $187.9M
Stockholders' Equity
Retained Earnings $-831.3M $-795.8M $-744.7M $-689.4M
Total Stockholders' Equity $381.0M $360.7M $368.8M $338.9M